# Study of ECC4703 With Sulfasalazine and Pitavastatin

> **NCT07726368** · PHASE1 · RECRUITING · sponsor: **Eccogene** · enrollment: 40 (estimated)

## Conditions studied

- Non-alcoholic Fatty Liver Disease (NAFLD)
- Dyslipidaemia

## Interventions

- **DRUG:** ECC4703
- **DRUG:** Sulfasalazine
- **DRUG:** Pitavastatin

## Key facts

- **NCT ID:** NCT07726368
- **Lead sponsor:** Eccogene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-07
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07726368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07726368, "Study of ECC4703 With Sulfasalazine and Pitavastatin". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07726368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*